In addition, we also analyzed the prognostic value of CD204+/CD169+ Mφs ratio, and found high CD204+/CD169+ Mφs ratio was correlated with poor survival in HCC patients (P < 0.001 Fig. 3d). Here, SIGLEC1 is linked to hepatocellular carcinoma.